β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients

NCT00672841 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Invasive Candidiasis

Interventions

DRUG: Preemptive Therapy with Anidulafungin
DRUG: Empiric antifungal therapy based on physician discretion.

Sponsor

Duke University

Collaborators

[object Object]